Biogen Inc.
BIIB
$129.77
$0.330.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.80% | 40.57% | 10.49% | -56.52% | -62.74% |
| Total Depreciation and Amortization | 33.75% | 36.05% | 32.62% | 21.54% | 8.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.81% | 34.31% | 73.56% | 300.55% | 138.97% |
| Change in Net Operating Assets | 62.50% | 76.08% | 15.84% | 42.46% | -135.90% |
| Cash from Operations | 56.93% | 85.85% | 56.44% | 24.90% | -1.95% |
| Capital Expenditure | 43.46% | 44.51% | 39.77% | 22.71% | -2.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 84.48% | 84.48% | 73.72% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.93% | -86.16% | -86.47% | 1,184.63% | 323.07% |
| Cash from Investing | 75.72% | 80.51% | 60.08% | -1,036.83% | -352.75% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 79.34% | 19.74% | -713.01% | -45.67% | -20.72% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.58% | 11.84% | 23.94% | 67.50% | -55.45% |
| Cash from Financing | -8.10% | -557.80% | -269.73% | 63.25% | 86.08% |
| Foreign Exchange rate Adjustments | -28.75% | -292.88% | 0.37% | -153.57% | 69.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.56% | 155.93% | 57.58% | -2,361.46% | -258.74% |